RT Journal Article SR Electronic T1 Evaluation of serum antibodies against SARS-CoVâ–ˇ2 in healthcare workers who participated in the operation of charter flights for the evacuation of Japanese residents from Hubei Province JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.03.17.21251964 DO 10.1101/2021.03.17.21251964 A1 Suzuki, Tetsuya A1 Hayakawa, Kayoko A1 Ainai, Akira A1 Iwata-Yoshikawa, Naoko A1 Sano, Kaori A1 Nagata, Noriyo A1 Suzuki, Tadaki A1 Wakimoto, Yuji A1 Akiyama, Yutaro A1 Miyazato, Yusuke A1 Nakamura, Keiji A1 Ide, Satoshi A1 Nomoto, Hidetoshi A1 Nakamoto, Takato A1 Ota, Masayuki A1 Moriyama, Yuki A1 Sugiki, Yuko A1 Saito, Sho A1 Morioka, Shinichiro A1 Ishikane, Masahiro A1 Kinoshita, Noriko A1 Kutsuna, Satoshi A1 Ohmagari, Norio YR 2021 UL http://medrxiv.org/content/early/2021/03/20/2021.03.17.21251964.abstract AB There are several recommendations for the use of personal protective equipment (PPE) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the selection of appropriate PPE for the current situation remains controversial. We measured serum antibody titers for SARS-CoV-2 in 10 participants who were engaged in the operation of charter flights for the evacuation of Japanese residents from Hubei Province. All participants wore PPE in accordance with Centers for Disease Control and Prevention guidelines. A total of 17 samples were tested, and all were seronegative. Hence, we conclude that the current PPE recommendation is effective to protect healthcare workers from SARS-CoV-2 infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the Emerging/Re-emerging Infectious Diseases Project of Japan, from the Japan Agency for Medical Research and Development, AMED under grant numbers JP19fk0108104 and JP19fk0108110, and Japan National Center for Global Health and Medicine (grant number 20A2003D).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was reviewed and approved by the Ethics Committee of the Center Hospital of the National Center for Global Health and Medicine. Written informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets of the current study are available from the corresponding author on reasonable request.